🇺🇸·4d agoResearch
Sevabertinib in Advanced HER2-Mutant Non-Small-Cell Lung Cancer. Reply
Publisher
P
PubMed NEJM RSS
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on pubmed.ncbi.nlm.nih.gov
Leave the platform to read the original full article on the publisher site.
Source: PubMed NEJM RSS
Scope: Research
Related coverage
More related coverage
PubMed Lancet Infectious Diseases RSS·2d ago
Treatment of multidrug-resistant Gram-negative infections: a stewardship imperative
PubMed Lancet Infectious Diseases RSS·2d ago
Survival trends in patients with difficult-to-treat, antibiotic-resistant, Gram-negative infections in the era of next-generation antibiotics in the USA: a retrospective cohort study
The Lancet·2d ago
[Editorial] Politicisation of the US FDA: eroding integrity and trust
The Lancet·2d ago